• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对源自HIV-1 gp120蛋白的非同源合成肽对产生的兔抗体的交叉反应性研究。

Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins.

作者信息

Krsmanovic V, Biquard J M, Sikorska-Walker M, Cosic I, Desgranges C, Trabaud M A, Whitfield J F, Durkin J P, Achour A, Hearn M T

机构信息

Centre de Génétique Moléculaire et Cellulaire, CNRS UMR 106, Université Claude Bernard Lyon I, Villeurbanne, France.

出版信息

J Pept Res. 1998 Nov;52(5):410-20. doi: 10.1111/j.1399-3011.1998.tb00665.x.

DOI:10.1111/j.1399-3011.1998.tb00665.x
PMID:9894846
Abstract

The immunological cross-reactivity of several peptides with specific pattern-property characteristics related to the epitopes of human immunodeficiency virus type 1 (HIV-1) gp160/ 120 envelope proteins has been investigated. Proteins with similar primary structures can be expected to show functional or topographic similarities, such as specific epitopes which may cross-react with antibodies derived from the immunisation of animals with other members of the same protein family. These structure-function characteristics may be revealed as periodicities derived from presentations based on the discrete Fourier transformation of the distributions of various physico-chemical amino acid descriptors, constituting the polypeptide backbone and amino acid side-chains of the protein molecule. Such approaches, for example, have permitted prediction of periodicities corresponding to secondary structural motifs, including amphipathic alpha-helices and beta-sheets, within protein sequences, and have helped to clarify potential binding sites for ligands, substrates or cofactors with interacting macromolecules. Based on this approach, characteristic periodicities have been identified which represent common Fourier transform spectral properties of the envelope (ENV) gp160/120 glycoproteins from a range of HIV-1 isolates. In addition, similar periodicities have been detected as components of the discrete Fourier transform representation of the corresponding amino acid descriptors of the CD4 binding domain of gp120. Accordingly, we have synthesised several peptides having periodic characteristics in their discrete Fourier transform representations similar to these HIV-1 proteins. These nonhomologous synthetic peptides induced cross-reactive antibodies in New Zealand White rabbits. Polyclonal antibodies raised to one of these peptides reacted with HIV-1 ENV gp120-related proteins, as determined by enzyme-linked immunosorbent assay and Western blotting techniques. These findings provide further evidence for a role of immunological cross-reactivity and molecular biomimicry in the development of peptide-based vaccines directed against viral or bacterial pathogens.

摘要

已对几种具有与人类免疫缺陷病毒1型(HIV-1)gp160/120包膜蛋白表位相关的特定模式特性的肽的免疫交叉反应性进行了研究。具有相似一级结构的蛋白质有望表现出功能或拓扑相似性,例如可能与用同一蛋白质家族的其他成员免疫动物产生的抗体发生交叉反应的特定表位。这些结构-功能特性可能表现为基于蛋白质分子多肽主链和氨基酸侧链的各种物理化学氨基酸描述符分布的离散傅里叶变换的呈现所产生的周期性。例如,此类方法已能够预测蛋白质序列中与二级结构基序相对应的周期性,包括两亲性α螺旋和β折叠,并有助于阐明与相互作用的大分子的配体、底物或辅因子的潜在结合位点。基于此方法,已鉴定出特征性周期性,这些周期性代表了一系列HIV-1分离株包膜(ENV)gp160/120糖蛋白的常见傅里叶变换光谱特性。此外,在gp120的CD4结合域的相应氨基酸描述符的离散傅里叶变换表示中也检测到了类似的周期性。因此,我们合成了几种在其离散傅里叶变换表示中具有与这些HIV-1蛋白相似的周期性特征的肽。这些非同源合成肽在新西兰白兔中诱导了交叉反应性抗体。通过酶联免疫吸附测定和蛋白质印迹技术测定,针对其中一种肽产生的多克隆抗体与HIV-1 ENV gp120相关蛋白发生反应。这些发现为免疫交叉反应性和分子仿生学在针对病毒或细菌病原体的基于肽的疫苗开发中的作用提供了进一步的证据。

相似文献

1
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins.针对源自HIV-1 gp120蛋白的非同源合成肽对产生的兔抗体的交叉反应性研究。
J Pept Res. 1998 Nov;52(5):410-20. doi: 10.1111/j.1399-3011.1998.tb00665.x.
2
Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.由HIV-1包膜糖蛋白免疫引起有害自身免疫反应的可能性不大。
AIDS Res Hum Retroviruses. 1993 Dec;9(12):1195-208. doi: 10.1089/aid.1993.9.1195.
3
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.一项关于具有天然和嵌合序列的合成HIV-1肽与津巴布韦、坦桑尼亚和瑞典HIV-1阳性血清反应性差异的调查。
AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002.
4
Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).应对来自人类免疫缺陷病毒1型(HIV-1)包膜糖蛋白的、可引发病毒中和抗体的免疫显性表位的高度变异性。
Mol Immunol. 1990 Jun;27(6):539-49. doi: 10.1016/0161-5890(90)90073-9.
5
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.一种三聚体HIV-1包膜糖蛋白120免疫原在兔和恒河猴中诱导出针对HIV-1的强效且广谱的抗V1V2环抗体。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01796-17. Print 2018 Mar 1.
6
Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).合成肽和抗肽抗体作为研究病毒组装过程中结构域间相互作用的探针:人类免疫缺陷病毒(HIV-1)包膜
Virology. 1992 May;188(1):1-13. doi: 10.1016/0042-6822(92)90729-9.
7
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.靶向HIV-1 gp120 V2区域的合理设计疫苗可诱导集中的、跨亚型反应性的、具有生物学功能的抗体反应。
J Virol. 2016 Nov 28;90(24):10993-11006. doi: 10.1128/JVI.01403-16. Print 2016 Dec 15.
8
Cross-reactive potential of rabbit antibodies raised against a cyclic peptide representing a chimeric V3 loop of HIV-1 gp120 studied by biosensor technique and ELISA.通过生物传感器技术和酶联免疫吸附测定法研究针对代表HIV-1 gp120嵌合V3环的环肽产生的兔抗体的交叉反应潜力。
FEMS Immunol Med Microbiol. 1994 Jun;9(1):77-87. doi: 10.1111/j.1574-695X.1994.tb00476.x.
9
Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines.
J Infect Dis. 1993 Dec;168(6):1396-403. doi: 10.1093/infdis/168.6.1396.
10
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.细胞间融合过程中人类免疫缺陷病毒包膜的抗原特性。
J Virol. 2001 Nov;75(22):11096-105. doi: 10.1128/JVI.75.22.11096-11105.2001.

引用本文的文献

1
Different SARS-CoV-2 variants inhibited by RRM designed peptide.RRM设计的肽对不同的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体具有抑制作用。
PLoS One. 2025 Jul 22;20(7):e0327582. doi: 10.1371/journal.pone.0327582. eCollection 2025.
2
Inhibition of β-lactamase function by de novo designed peptide.新型设计肽抑制β-内酰胺酶功能。
PLoS One. 2023 Sep 8;18(9):e0290845. doi: 10.1371/journal.pone.0290845. eCollection 2023.
3
Environmental Light and Its Relationship with Electromagnetic Resonances of Biomolecular Interactions, as Predicted by the Resonant Recognition Model.
环境光及其与生物分子相互作用的电磁共振的关系,如共振识别模型所预测的那样。
Int J Environ Res Public Health. 2016 Jun 29;13(7):647. doi: 10.3390/ijerph13070647.
4
Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.慢性丙型肝炎感染中肝脏病变与心脏副交感神经调节的共同分子机制:M3型毒蕈碱受体的关键作用
BMC Bioinformatics. 2016 Mar 22;17:139. doi: 10.1186/s12859-016-0988-7.
5
MSCA: a spectral comparison algorithm between time series to identify protein-protein interactions.MSCA:一种用于识别蛋白质-蛋白质相互作用的时间序列间光谱比较算法。
BMC Bioinformatics. 2015 May 13;16:152. doi: 10.1186/s12859-015-0599-8.
6
Biological effects of a de novo designed myxoma virus peptide analogue: evaluation of cytotoxicity on tumor cells.新型兔粘液瘤病毒肽类似物的生物学效应:评估其对肿瘤细胞的细胞毒性。
PLoS One. 2011;6(9):e24809. doi: 10.1371/journal.pone.0024809. Epub 2011 Sep 19.
7
Induction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptide.通过非同源合成肽诱导人免疫缺陷病毒(HIV-1)包膜特异性细胞介导免疫
PLoS One. 2007 Nov 28;2(11):e1214. doi: 10.1371/journal.pone.0001214.
8
Bioactive peptide design using the Resonant Recognition Model.使用共振识别模型进行生物活性肽设计。
Nonlinear Biomed Phys. 2007 Jul 19;1(1):7. doi: 10.1186/1753-4631-1-7.